Flouxetine pharmaceutical formulations
US5747068A · kind A · utility
45Cited by
14References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 18, 1995 |
| Grant date | May 5, 1998 |
| Priority date | — |
| Expiry date | Jul 18, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical formulations of fluoxetine or an acid addition salt thereof, suitable for manufacturing dispersible tablets by direct compression and comprising, in addition to the active ingredient, the appropriate excipients and coadjuvants, selected from among disintegrants, diluents, lubricants, anti-adherents, sweeteners, flavorings and, optionally, colorants. Said formulations are suitable for manufacturing dispersible tablets which disintegrate in less than three minutes in water at 19.degree. C.-21.degree. C., and are appropriate for treatment of depression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.